Aliases & Classifications for Cystadenoma

MalaCards integrated aliases for Cystadenoma:

Name: Cystadenoma 12 56 45 15 74
Craniopharyngioma 74
Cystoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:2634
MeSH 45 D003537
NCIt 51 C2972
SNOMED-CT 69 47620003

Summaries for Cystadenoma

Disease Ontology : 12 An adenoma that forms a cyst.

MalaCards based summary : Cystadenoma, also known as craniopharyngioma, is related to mucinous ovarian cystadenoma and pancreatic serous cystadenoma, and has symptoms including visual disturbance An important gene associated with Cystadenoma is KRT7 (Keratin 7), and among its related pathways/superpathways is Ovarian Infertility Genes. The drugs Ethanol and Anti-Infective Agents, Local have been mentioned in the context of this disorder. Affiliated tissues include pancreas, ovary and appendix.

Related Diseases for Cystadenoma

Diseases related to Cystadenoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 438)
# Related Disease Score Top Affiliating Genes
1 mucinous ovarian cystadenoma 33.9 KRT7 MUC1 SYP
2 pancreatic serous cystadenoma 33.2 CHGA KRT7 PGR SYP VHL
3 pancreatic mucinous cystadenoma 32.9 KRT20 KRT7 MME MUC1 PGR
4 cystadenocarcinoma 32.6 KRT7 MUC1 PGR
5 appendix adenocarcinoma 32.5 KRT20 KRT7
6 microcystic adenoma 32.2 INHA MUC1 MUC6 VHL
7 von hippel-lindau syndrome 30.7 CHGA INHA VHL
8 hidradenoma 30.5 KRT7 MUC1
9 carcinoid syndrome 30.4 CHGA SYP
10 mucinous cystadenocarcinoma 30.4 KRT20 KRT7 MUC1
11 goblet cell carcinoid 30.4 CHGA KRT20
12 rectum adenocarcinoma 30.2 KRT20 KRT7
13 pseudomyxoma peritonei 30.2 KRT20 KRT7 MUC1 MUC6
14 apocrine adenocarcinoma 30.2 MUC1 PGR
15 bile duct cystadenocarcinoma 30.2 KRT20 KRT7 MUC1 MUC6
16 cystic teratoma 30.1 KRT20 KRT7 MUC6 SYP
17 endosalpingiosis 30.1 KRT7 MUC1 PGR
18 sertoli-leydig cell tumor 30.1 KRT7 MUC1 PGR
19 eccrine papillary adenocarcinoma 30.0 KRT7 PGR
20 adenosarcoma 30.0 MME PGR
21 smooth muscle tumor 30.0 MME PGR
22 mucoepidermoid carcinoma 29.9 CHGA KRT7 MUC1
23 mucinous adenocarcinoma 29.9 KRT20 KRT7 MUC1
24 papillary adenocarcinoma 29.8 KRT7 MUC1 PGR
25 clear cell papillary renal cell carcinoma 29.8 KRT7 MME VHL
26 adenofibroma 29.8 INHA MME MUC1
27 renal cell carcinoma, nonpapillary 29.7 KRT20 KRT7 MME MUC1 VHL
28 endocrine gland cancer 29.7 CHGA MUC1 SYP
29 horseshoe kidney 29.7 CHGA KRT20 KRT7 SYP
30 renal cell carcinoma, papillary, 1 29.6 KRT7 MME VHL
31 endodermal sinus tumor 29.6 CHGA KLK3
32 oncocytoma 29.6 KRT7 MME MUC1 SYP
33 papillary carcinoma 29.6 KRT20 KRT7 MUC1 PGR
34 appendix cancer 29.6 KRT20 KRT7 MUC1 MUC6
35 prostatic hyperplasia, benign 29.5 KLK3 SERPINA3
36 neuroendocrine tumor 29.5 CHGA KRT20 KRT7 SYP
37 dermoid cyst 29.5 CHGA KRT20 KRT7 MUC1 PGR
38 clear cell renal cell carcinoma 29.5 KRT7 MME MUC1 VHL
39 cystadenofibroma 29.4 INHA KRT20 KRT7 MME MUC1
40 ovarian mucinous neoplasm 29.4 KRT20 KRT7 MUC6 SYP
41 cholangiocarcinoma 29.4 KRT20 KRT7 MME MUC1
42 ovarian cystadenoma 12.5
43 ovarian papillary cystadenoma 12.4
44 ovarian endometrioid cystadenoma 12.3
45 pancreatic cystadenoma 12.2
46 seminal vesicle cystadenoma 12.2
47 bile duct cystadenoma 12.2
48 pancreatic colloid cystadenoma 12.2
49 serous or mucinous cystadenoma of childhood 12.1
50 rete ovarii cystadenoma 12.0

Graphical network of the top 20 diseases related to Cystadenoma:



Diseases related to Cystadenoma

Symptoms & Phenotypes for Cystadenoma

UMLS symptoms related to Cystadenoma:


visual disturbance

Drugs & Therapeutics for Cystadenoma

Drugs for Cystadenoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 16)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ethanol Approved Phase 2, Phase 3,Phase 1,Not Applicable 64-17-5 702
2 Anti-Infective Agents, Local Phase 2, Phase 3,Phase 1,Not Applicable
3 Central Nervous System Depressants Phase 2, Phase 3,Phase 1,Not Applicable
4 Anti-Infective Agents Phase 2, Phase 3,Phase 1,Not Applicable
5
Pancrelipase Approved, Investigational Phase 1,Not Applicable 53608-75-6
6
Paclitaxel Approved, Vet_approved Phase 1,Not Applicable 33069-62-4 36314
7 pancreatin Phase 1,Not Applicable
8 Albumin-Bound Paclitaxel Phase 1,Not Applicable
9 Hemostatics Phase 1
10 Antineoplastic Agents, Phytogenic Phase 1,Not Applicable
11 Antimitotic Agents Phase 1,Not Applicable
12 Antibiotics, Antitubercular Phase 1
13 Anti-Bacterial Agents Phase 1
14 Gastrointestinal Agents Not Applicable
15 Anesthetics Not Applicable
16 Pharmaceutical Solutions Not Applicable

Interventional clinical trials:

(show all 16)
# Name Status NCT ID Phase Drugs
1 Laser Therapy of Benign Thyroid Nodules Unknown status NCT00150150 Phase 3
2 Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy Unknown status NCT02097446 Phase 3
3 EUS-Guided Pancreatic Injection of Cyst (EPIC) Trial Completed NCT00233038 Phase 2, Phase 3
4 Laser Tissue Welding - Distal Pancreatectomy Sealing Study Recruiting NCT03147768 Phase 1
5 Endoscopic Ultrasound (EUS) Guided Ethanol With Paclitaxel Ablation for Pancreatic Mucinous Cystic Neoplasm Terminated NCT01525706 Phase 1 Ethanol and Paclitaxel Injection
6 A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas Unknown status NCT02523170 Not Applicable
7 Endoscopic Ultrasound Guided Radiofrequency Ablation (EUS-RFA) for Small Benign Pancreatic Tumors Unknown status NCT02882503 Not Applicable
8 Ovarian Clear Cell Adenocarcinoma Review Completed NCT02129036
9 Efficacy and Safety of Radiofrequency Ablation in Pancreatic Neuroendocrine and Cystic Tumor Completed NCT02330497 Not Applicable
10 Treg, Th17 Cells, NKT in Epithelial Ovarian Tumor Completed NCT03779399
11 Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts Recruiting NCT01643460 Not Applicable
12 MyVHL: Patient Natural History Study Recruiting NCT03749980
13 Feasibility of Molecular Biology in Pancreatic Cyst Tumors Recruiting NCT03305146 Not Applicable
14 Incidence of POPF in the Resection of the Left Pancreas With RFAT Recruiting NCT03570502
15 Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging - A Report of Accuracy Active, not recruiting NCT03884179
16 Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions Terminated NCT02494388

Search NIH Clinical Center for Cystadenoma

Cochrane evidence based reviews: cystadenoma

Genetic Tests for Cystadenoma

Anatomical Context for Cystadenoma

MalaCards organs/tissues related to Cystadenoma:

42
Pancreas, Ovary, Appendix, Pituitary, Liver, Breast, Prostate

Publications for Cystadenoma

Articles related to Cystadenoma:

(show top 50) (show all 2904)
# Title Authors Year
1
Pancreatic mucinous cystadenoma doubly complicated by acute pancreatitis and retroperitoneal rupture. ( 30197176 )
2019
2
Pituitary Adenoma and Craniopharyngioma Collision Tumor: Diagnostic, Treatment Considerations, and Review of the Literature. ( 30326307 )
2019
3
Detailed assessment of hypothalamic damage in craniopharyngioma patients with obesity. ( 30181653 )
2019
4
Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review. ( 30247642 )
2019
5
Trans-eyebrow supraorbital keyhole approach in suprasellar and third ventricular craniopharyngioma surgery: the experience of 27 cases and a literature review. ( 30392089 )
2019
6
Superficial Siderosis Associated with Craniopharyngioma. ( 30529527 )
2019
7
Management of Hypothalamic Disease in Patients with Craniopharyngioma. ( 30614015 )
2019
8
Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. ( 30616515 )
2019
9
Management of Craniopharyngioma. ( 30640850 )
2019
10
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma. ( 30645190 )
2019
11
Growth hormone replacement therapy improves hypopituitarism-associated hypoxemia in a patient after craniopharyngioma surgery: A case report. ( 30653131 )
2019
12
Adipsic diabetes insipidus secondary to craniopharyngioma resection. ( 30709829 )
2019
13
Patterns of Care in Pediatric Craniopharyngioma: Outcomes Following Definitive Radiotherapy. ( 30711960 )
2019
14
Craniopharyngioma: 10 Selected Works That Provide Comprehensive and Valuable Insight into These Complex Tumors. ( 30716873 )
2019
15
In Reply to the Letter to the Editor "Craniopharyngioma: 10 Selected Works Which Provide Comprehensive and Valuable Insight into These Complex Tumors". ( 30716874 )
2019
16
Subfrontal Infrachiasmatic Approach to a Craniopharyngioma Resection: 2-Dimensional Operative Video. ( 30726971 )
2019
17
Efficacy of Direct Revascularization Surgery for Hemorrhagic Moyamoya Syndrome As a Late Complication of Cranial Irradiation for Childhood Craniopharyngioma. ( 30772161 )
2019
18
Intrachiasmatic craniopharyngioma: Assessment of visual outcome with optical coherence tomography after complete surgical removal. ( 30775061 )
2019
19
MANAGEMENT OF ENDOCRINE DISEASE: Childhood-onset Craniopharyngioma: state of the art of care in 2018. ( 30817319 )
2019
20
Anterior cerebral artery rupture during extended endoscopic endonasal transsphenoidal approach for severely calcified craniopharyngioma. ( 30844531 )
2019
21
An ectopic recurrent craniopharyngioma of the temporal lobe: Case report and review of the literature. ( 30877004 )
2019
22
Pediatric craniopharyngioma in association with familial adenomatous polyposis. ( 30919136 )
2019
23
Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. ( 30925462 )
2019
24
Endocrine and Visual Outcomes Following Gross Total Resection and Subtotal Resection of Adult Craniopharyngioma: Systematic Review and Meta-Analysis. ( 30947004 )
2019
25
Intraoperative finding of an Anterior Communicating Artery Blister-like Aneurysm during a Primary Craniopharyngioma Resection: Accidental or Incidental? ( 30986581 )
2019
26
Editorial. Patient outcomes following treatment for craniopharyngioma. ( 31003216 )
2019
27
Eating behaviour and oxytocin in patients with childhood-onset craniopharyngioma and different grades of hypothalamic involvement. ( 31013553 )
2019
28
Frequent B7-H3 overexpression in craniopharyngioma. ( 31043272 )
2019
29
Cognitive Performance, Aerobic Fitness, Motor Proficiency, and Brain Function Among Children Newly Diagnosed With Craniopharyngioma. ( 31050329 )
2019
30
A case of Ureaplasma parvum meningitis in an adult after transphenoidal ablation of cranopharyngioma. ( 31051277 )
2019
31
Prediction of calcification tendency in pediatric cystic adamantinomatous craniopharyngioma by using inflammatory markers, hormone markers, and radiological appearances. ( 31062140 )
2019
32
Management of postoperative vasospasm following endoscopic endonasal surgery for craniopharyngioma: Report and review of literature. ( 31085895 )
2019
33
Papillary craniopharyngioma in a 4-year-old girl with BRAF V600E mutation: a case report and review of the literature. ( 30069716 )
2019
34
Bilateral Polycystic Kidneys and Focal Renal Cystadenoma in a Pygmy Sperm Whale ( Kogia breviceps). ( 30235083 )
2019
35
The honeycomb pattern of pancreatic serous cystadenoma. ( 30288583 )
2019
36
Mucinous Cystadenoma of the Urachus and Review of Current Classification of Urachal Mucinous Cystic Neoplasms. ( 30398914 )
2019
37
Laparoscopic vesiculectomy for large seminal vesicle cystadenoma. ( 30488974 )
2019
38
Cystadenoma of the Seminal Vesicle: A Case Report of Rare Seminal Vesical Tumor and Review of Literature. ( 30599918 )
2019
39
Papillary cystadenoma of the parotid gland: A case report. ( 30746378 )
2019
40
Giant multilocular prostatic cystadenoma. ( 30808350 )
2019
41
Benign Ovarian Tumors in Pregnancy: A Case Report of Metachronous Ipsilateral Recurrent Mucinous Cystadenoma in Initial Pregnancy and Mature Cystic Teratoma in Subsequent Pregnancy. ( 30868032 )
2019
42
Giant serous cystadenoma of the pancreas appearing sonographically as a remote pararenal mass. ( 30907433 )
2019
43
Misdiagnosis of Intrahepatic Biliary Cystadenoma Located in Caudate Lobe: A Case Report. ( 30947661 )
2019
44
An Extremely Giant Ovarian Mucinous Cystadenoma. ( 30956200 )
2019
45
Ruptured cystic teratoma associated with mucinous cystadenoma in a pregnant woman. ( 30975966 )
2019
46
Giant Primary Retroperitoneal Serous Cystadenoma: A Rare Entity Mimicking Multiple Neoplastic and Nonneoplastic Processes. ( 31017452 )
2019
47
Macrocystic serous cystadenoma of the pancreas. ( 31023580 )
2019
48
Report: Laparoscopic management for coexistent parasitic ovarian teratoma of the omentum and ovarian mucinous cystadenoma: A case report. ( 31081783 )
2019
49
Laparoscopic Resection of a Primary Retroperitoneal Mucinous Cystadenoma. ( 31097932 )
2019
50
A rare challenging case of co-existent craniopharyngioma, acromegaly and squamous cell lung cancer. ( 29623208 )
2018

Variations for Cystadenoma

Expression for Cystadenoma

Search GEO for disease gene expression data for Cystadenoma.

Pathways for Cystadenoma

Pathways related to Cystadenoma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.13 INHA PGR

GO Terms for Cystadenoma

Cellular components related to Cystadenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 neuron projection terminus GO:0044306 8.62 MME SYP

Biological processes related to Cystadenoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 maintenance of gastrointestinal epithelium GO:0030277 8.62 MUC6 SERPINA3

Sources for Cystadenoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....